By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Northwest Biotherapeutics, Inc. 

21720 23rd Drive SE
Suite 100
Bothell  Washington  98021  U.S.A.
Phone: 425-608-3000-or-877-606-9246-Toll-Free Fax: 425-608-3026




Cytogen Corporation  Development of ex vivo prostate cancer immunotherapy

Company News
NW Bio (NWBO) Has Entered Into An Agreement For $30 Million Of New Equity Funding From Woodford Investment Management 10/21/2015 10:44:53 AM
NW Bio (NWBO) Issues Statement On Highly Unusual Trading Activity 10/20/2015 12:19:19 PM
NW Bio (NWBO) Temporarily Halts Patient Screening for DCVax-L Brain Cancer Study 8/24/2015 6:13:58 AM
Northwest Biotherapeutics (NWBO) Announces Data To Date From DCVax-Direct Phase I Trial 6/1/2015 8:41:29 AM
Northwest Biotherapeutics (NWBO) To Present Overview Of DCVax-Direct Phase I Trial In Chicago This Weekend 5/27/2015 10:08:07 AM
Northwest Biotherapeutics (NWBO) To Present At New York Academy of Sciences' Conference On Emerging Approaches To Immunotherapy 5/22/2015 6:19:38 AM
Northwest Biotherapeutics (NWBO) To Webcast, Live, at On May 7 5/7/2015 11:58:38 AM
Northwest Biotherapeutics (NWBO) To Webcast, Live, At Virtualinvestorconferences.Com On May 7 5/6/2015 11:17:39 AM
Northwest Biotherapeutics (NWBO) Rakes In $28.5 Million 5/1/2015 9:10:40 AM
Northwest Biotherapeutics (NWBO) Featured In Presentations At The AACR Annual Meeting 4/21/2015 1:17:27 PM